Keros Therapeutics Inc(KROS):预期营收0.00;
    Crispr Therapeutics AG(CRSP):预期营收6.65M;
    阿维亚网络公司(AVNW):预期营收95.65M;
    Navios Maritime Partners LP Unit(NMM):预期营收338.33M;
    Frontier Communications Parent Inc(FYBR):预期营收1.46B;
    Karyopharm Therapeutics Inc(KPTI):预期营收38.12M;
    UFP Technologies Inc(UFPT):预期营收132.03M;
    Oxford Square Capital Corp.(OXSQ):预期营收11.8M;
    MacroGenics Inc(MGNX):预期营收87.61M;
    AG Mortgage Investment Trust Inc(MITT):预期营收16.46M;
    Hyster-Yale Materials Handling Inc(HY):预期营收1.04B;
    Syndax Pharmaceuticals Inc(SNDX):预期营收9.16M;
    Beam Therapeutics Inc(BEAM):预期营收14.52M;
    Ultragenyx Pharmaceutical Inc(RARE):预期营收135.28M;
    Key Tronic Corp.(KTCC):预期营收--;
    The Eastern Co.(EML):预期营收--;
    Orezone Gold Corp(ORZCF):预期营收66.4M;
    景顺抵押资本(IVR):预期营收49.9M;
    Bristow Group Inc(VTOL):预期营收340.4M;
    布鲁克(BRKR):预期营收866.46M;